Evelo Biosciences, Inc.
Total Trades
36
Buys
5
Sells
18
Largest Trade
N/A
Insiders
8
Institutional Funds
2
Inst. Value
$1M+
Activist Filings
15
Insider Trades
| Insider | Title | Type | Value | Shares | Price | Date |
|---|---|---|---|---|---|---|
| Bodmer Mark | CSO | SELL | $1K–$15K | 3K | $0.33 | Nov 9, 2023 |
| Bodmer Mark | CSO | EXERCISE | N/A | 7K | — | Nov 9, 2023 |
| McHale Duncan | Chief Medical Offi… | EXERCISE | N/A | 7K | — | Nov 9, 2023 |
| McHale Duncan | Chief Medical Offi… | SELL | $1K–$15K | 3K | $0.33 | Nov 9, 2023 |
| GILL SIMBA | President & CEO | SELL | <$1K | 172 | $0.33 | Nov 9, 2023 |
| GILL SIMBA | President & CEO | EXERCISE | N/A | 1K | — | Nov 9, 2023 |
| Thorell Marella | CFO | SELL | <$1K | 2K | $0.33 | Nov 9, 2023 |
| Thorell Marella | CFO | EXERCISE | N/A | 7K | — | Nov 9, 2023 |
| Bodmer Mark | CSO | SELL | $1K–$15K | 7K | $0.33 | Nov 3, 2023 |
| Bodmer Mark | CSO | EXERCISE | N/A | 13K | — | Nov 3, 2023 |
| McHale Duncan | Chief Medical Offi… | SELL | $1K–$15K | 7K | $0.33 | Nov 3, 2023 |
| McHale Duncan | Chief Medical Offi… | EXERCISE | N/A | 13K | — | Nov 3, 2023 |
| Thorell Marella | CFO | SELL | $1K–$15K | 4K | $0.33 | Nov 3, 2023 |
| Thorell Marella | CFO | EXERCISE | N/A | 13K | — | Nov 3, 2023 |
| GILL SIMBA | President & CEO | SELL | $1K–$15K | 2K | $3.94 | Sep 29, 2023 |
| GILL SIMBA | President & CEO | EXERCISE | N/A | 15K | — | Sep 29, 2023 |
| Bodmer Mark | CSO | EXERCISE | N/A | 7K | — | Aug 10, 2023 |
| Bodmer Mark | CSO | SELL | $15K–$50K | 3K | $9.51 | Aug 10, 2023 |
| GILL SIMBA | President & CEO | SELL | $1K–$15K | 342 | $9.51 | Aug 10, 2023 |
| GILL SIMBA | President & CEO | EXERCISE | N/A | 1K | — | Aug 10, 2023 |
| McHale Duncan | Chief Medical Offi… | SELL | $15K–$50K | 3K | $9.51 | Aug 10, 2023 |
| McHale Duncan | Chief Medical Offi… | EXERCISE | N/A | 7K | — | Aug 10, 2023 |
| Thorell Marella | CFO | EXERCISE | N/A | 7K | — | Aug 10, 2023 |
| Thorell Marella | CFO | SELL | $15K–$50K | 2K | $9.51 | Aug 10, 2023 |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | BUY | $1M+ | 5.4M | $2.31 | Jul 13, 2023 |
| Bodmer Mark | CSO | SELL | $1K–$15K | 23K | $0.14 | Jun 12, 2023 |
| McHale Duncan | Chief Medical Offi… | SELL | $1K–$15K | 67K | $0.13 | May 11, 2023 |
| Bodmer Mark | CSO | SELL | $1K–$15K | 68K | $0.13 | May 11, 2023 |
| Thorell Marella | CFO | SELL | $1K–$15K | 39K | $0.13 | May 11, 2023 |
| GILL SIMBA | President & CEO | SELL | <$1K | 4K | $0.13 | May 11, 2023 |
| CARRIERE STEPHEN J | Principal Accounti… | SELL | <$1K | 151 | $1.06 | Jan 23, 2023 |
| CARRIERE STEPHEN J | Principal Accounti… | EXERCISE | N/A | 354 | — | Jan 23, 2023 |
| Flagship Ventures Fund IV General Partner LLC | 10% Owner | BUY | $1M+ | 27.4M | $1.46 | Jun 1, 2022 |
| McHale Duncan | Chief Medical Offi… | BUY | $15K–$50K | 34K | $1.46 | May 31, 2022 |
| Darzi Lord Ara | Director | BUY | $100K–$500K | 342K | $1.46 | May 31, 2022 |
| Epstein David R | Director | BUY | $15K–$50K | 17K | $1.46 | May 31, 2022 |
Institutional Ownership
13F filings as of Sep 30, 2023 · 2 funds holding
| Fund | Shares | Value | Type |
|---|---|---|---|
| VANGUARD GROUP INC | 358K | $1M+ | SH |
| CITIGROUP INC | 2K | $1K–$15K | SH |
Activist & 5%+ Owners
SC 13D/13G filings — investors holding 5%+ of outstanding shares
SC 13G/A · Dec 11, 2023
0.0%
0 shares
SC 13G/A · Nov 13, 2023
7.0%
1.3M shares
SC 13G · Aug 10, 2023
14.8%
2.5M shares
Horizon Technology Finance Corporation
SC 13G · Jul 21, 2023
11.5%
2.2M shares
SC 13G · Jul 21, 2023
8.8%
1.5M shares
SC 13D/A · Jul 13, 2023
0.2%
34K shares
SC 13G/A · Jul 10, 2023
2.3%
126K shares
SC 13G/A · Jun 12, 2023
8.7%
9.8M shares
SC 13D/A · Feb 21, 2023
5.0%
5 shares
SC 13G/A · Feb 14, 2023
2.8%
3.1M shares
SC 13G/A · Feb 2, 2023
3.4%
3.7M shares
SC 13D/A · Nov 21, 2022
5.6%
6 shares
SC 13D/A · Aug 23, 2022
3.6%
3 shares
SC 13D/A · Jun 1, 2022
0.6%
684K shares
SC 13G/A · Feb 14, 2022
6.7%
3.6M shares